FDA Approved: XURIDEN — Supplemental Application (BTG International Inc)

View source ↗

Summary

The FDA approved a supplemental application for XURIDEN (uridine triacetate) submitted by BTG International Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Orotic Aciduria

Drugs mentioned

• XURIDEN (uridine triacetate)

Snippet

SUPPL AP for XURIDEN (URIDINE TRIACETATE)